FDA Extends Trials for Cladribine
Cladribine is a new oral medication, manufactured by Merck KGaA, designed to treat patients with multiple sclerosis. This medication has been under intense scrutiny in both the United States and in Europe. The European regulators recently advised against approving the medication but the FDA feels the drug deserves a closer examination. This is significant because […]
